Structures by: Palmore G. T.
Total: 18
Pyridinium trifluoroacetate
(C5H6N),(C2F3O2)
Acta Crystallographica Section C (1997) 53, 12 1904-1907
a=14.493(2)Å b=14.493(2)Å c=10.191(2)Å
α=90.00° β=90.00° γ=120.00°
C22H20N6O8Zn
C22H20N6O8Zn
Crystal Growth & Design (2004) 4, 6 1203
a=11.8449(4)Å b=8.2760(3)Å c=13.0727(5)Å
α=90.00° β=116.7000(10)° γ=90.00°
C22H20N6NiO8
C22H20N6NiO8
Crystal Growth & Design (2004) 4, 6 1203
a=11.8260(5)Å b=8.2955(3)Å c=13.0456(5)Å
α=90.00° β=116.6910(10)° γ=90.00°
C22H20CoN6O8
C22H20CoN6O8
Crystal Growth & Design (2004) 4, 6 1203
a=11.8182(6)Å b=8.2857(4)Å c=13.0625(6)Å
α=90.00° β=116.5640(10)° γ=90.00°
Bis(imidazolium 2,6-dicaroboxypyridine) Cu(II)
C22H20CuN6O8
Crystal Growth & Design (2004) 4, 6 1203
a=13.0714(7)Å b=8.2440(3)Å c=11.9058(5)Å
α=90.00° β=117.1960(10)° γ=90.00°
C44H40CuMnN12O16
C44H40CuMnN12O16
Crystal Growth & Design (2004) 4, 6 1203
a=11.8819(4)Å b=8.2462(3)Å c=13.0763(5)Å
α=90.00° β=116.9050(10)° γ=90.00°
Diketopiperazine + chloranillic acid
C10H8Cl2N2O6
Crystal Growth & Design (2002) 2, 5 337
a=9.8283(11)Å b=6.1935(7)Å c=10.6465(12)Å
α=90.00° β=106.616(2)° γ=90.00°
Diketopiperazine + 2,5-dichlorohydroquinone
C10H10Cl2N2O4
Crystal Growth & Design (2002) 2, 5 337
a=8.895(2)Å b=5.1184(12)Å c=12.390(3)Å
α=90.00° β=107.169(3)° γ=90.00°
DKP.2PPA
C10H10N2O6
Crystal Growth & Design (2002) 2, 5 337
a=9.3740(6)Å b=29.318(2)Å c=12.5881(9)Å
α=90.00° β=102.958(2)° γ=90.00°
Diketopiperazine + 2,5-dihydroxybenzoic acid
C11H12N2O6
Crystal Growth & Design (2002) 2, 5 337
a=26.3318(11)Å b=6.3550(3)Å c=12.9136(5)Å
α=90.00° β=90.00° γ=90.00°
Diketopiperazine + 2,5-dichlorobenzoic acid
C18H14Cl4N2O6
Crystal Growth & Design (2002) 2, 5 337
a=3.8469(2)Å b=6.1731(4)Å c=40.630(3)Å
α=90.00° β=90.7800(10)° γ=90.00°
Diketopiperazine + fumaric acid
C8H10N2O6
Crystal Growth & Design (2002) 2, 5 337
a=5.9359(9)Å b=6.5936(9)Å c=7.3042(10)Å
α=109.262(3)° β=90.762(3)° γ=116.527(2)°
Diketopiperazine + 5-chlorosalicylic acid
C18H16Cl2N2O8
Crystal Growth & Design (2002) 2, 5 337
a=11.816(2)Å b=5.4552(10)Å c=14.331(3)Å
α=90.00° β=98.255(2)° γ=90.00°
Diketopiperazine + 2,5-dichloroterephthalic acid
C12H10Cl2N2O6
Crystal Growth & Design (2002) 2, 5 337
a=6.6393(12)Å b=6.9913(13)Å c=7.0627(14)Å
α=100.371(4)° β=97.433(4)° γ=92.838(4)°
Diketopiperazine + 2,5-dydroxyterephthalic acid
C12H12N2O6
Crystal Growth & Design (2002) 2, 5 337
a=6.5698(9)Å b=6.6864(10)Å c=6.9614(10)Å
α=97.890(3)° β=93.110(3)° γ=93.426(3)°
Diketopiperazine + 2,5-dihydroxybenzoquinone
C10H10N2O6
Crystal Growth & Design (2002) 2, 5 337
a=5.3223(19)Å b=7.831(3)Å c=12.080(4)Å
α=99.815(7)° β=91.105(7)° γ=91.279(9)°
Diketopiperazine + 2,5-dihydroxybenzoquinone
C10H10N2O6
Crystal Growth & Design (2002) 2, 5 337
a=12.080(4)Å b=6.278(2)Å c=6.788(2)Å
α=90.00° β=95.017(7)° γ=90.00°
Wb31jul13
C43H45MoN4P3
Organometallics (2014) 140625141928007
a=43.141(8)Å b=9.2291(18)Å c=21.136(5)Å
α=90° β=107.892(12)° γ=90°